A Quality-Adjusted Price Index for Colorectal Cancer Drugs

Claudio Lucarelli, Sean Nicholson

NBER Working Paper No. 15174
Issued in July 2009

---- Acknowledgements -----

Excellent research assistance was provided by Brigid Farrell and Artem Gulish. The Merck Foundation, Pfizer, Inc., Johnson & Johnson, and AstraZeneca provided funding for the study. We thank IntrinsiQ, Jeff Forringer, Robert Ruckman, Andrew Epstein, and Scott Johnson for providing and interpreting the data, and Josh Bilenker and Brad Somer for information about oncology generally. Helpful comments were also provided by Daniel Eisenberg, Will Manning, Alan Garber, Amitabh Chandra, and seminar participants at Academy Health, the Pharmaceutical Economics and Policy Council, the Federal Trade Commission, the University of Chicago, Duke University, the Missoula Tumor Board, and NBER. The views expressed herein are those of the author(s) and do not necessarily reflect the views of the National Bureau of Economic Research.

return to bibliography page